MedTrace Logo

Rapid dEvice Testing pROtocol for Parkinson's Disease

NCT04675853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2022-07-22

No results posted yet for this study

Summary

This is an 8 week observational study to evaluate the feasibility of using remote monitoring technologies in future studies of PD. The study will 2 clinical evaluations (one initial, one final), and an 8-week monitoring period including 4 virtual visits where participants will use a combination of digital devices (Emerald touchless sensor system with associated ankle accelerometer, iPhone, Apple Watch, iPad, Fitbit Aria, FitBit Versa, Withings Blood Pressure Monitor Connect, and/or Withings Sleep Mat) during their daily lives.

Conditions

  • Healthy
  • Parkinson Disease

Sponsors & Collaborators

  • HealthMode Inc.

    lead INDUSTRY

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-25
Primary Completion
2021-11-25
Completion
2021-11-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04675853 on ClinicalTrials.gov